Allele-specific expression and high-throughput reporter assay reveal functional genetic variants associated with alcohol use disorders
暂无分享,去创建一个
Andy B. Chen | Yunlong Liu | A. Goate | T. Foroud | T. Skaar | H. Edenberg | J. Tischfield | X. Rao | S. Farris | R. Mayfield | Yue Wang | Hai Lin | X. Xuei | D. Lai | M. Kapoor | Hongyu Gao | J. Reiter | Katherine A. Hargreaves | A. Chen | H. Gu | Kriti S Thapa | Joseph Ipe | Sean P Farris | A. Goate | Manav Kapoor | Jill L Reiter | Todd C. Skaar | Todd C Skaar
[1] J. McClintick,et al. Alcohol Dehydrogenases, Aldehyde Dehydrogenases, and Alcohol Use Disorders: A Critical Review , 2018, Alcoholism, clinical and experimental research.
[2] David Haussler,et al. The UCSC Genome Browser database: 2019 update , 2018, Nucleic Acids Res..
[3] S. McWeeney,et al. Regional Differences and Similarities in the Brain Transcriptome for Mice Selected for Ethanol Preference From HS-CC Founders , 2018, Front. Genet..
[4] H. Kranzler,et al. Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review , 2018, JAMA.
[5] Yunlong Liu,et al. PASSPORT-seq: A Novel High-Throughput Bioassay to Functionally Test Polymorphisms in Micro-RNA Target Sites , 2018, Front. Genet..
[6] Sarah M. Hartz,et al. Trans-ancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders , 2018, Nature Neuroscience.
[7] Nicola J. Rinaldi,et al. Genetic effects on gene expression across human tissues , 2017, Nature.
[8] R. Mayfield,et al. Gene expression profiling in the human alcoholic brain , 2017, Neuropharmacology.
[9] C. Harrington,et al. Effects of selection for ethanol preference on gene expression in the nucleus accumbens of HS‐CC mice , 2017, Genes, brain, and behavior.
[10] Helen E. Parkinson,et al. The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog) , 2016, Nucleic Acids Res..
[11] K. Grant,et al. Opposing effects of alcohol on the immune system , 2016, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[12] D. Herr,et al. Role of sphingomyelinases in neurological disorders , 2015, Expert opinion on therapeutic targets.
[13] H. Kranzler,et al. Alcohol Dependence Genetics: Lessons Learned From Genome-Wide Association Studies (GWAS) and Post-GWAS Analyses. , 2015, Alcoholism, clinical and experimental research.
[14] D. Bartel,et al. Predicting effective microRNA target sites in mammalian mRNAs , 2015, eLife.
[15] Carson C Chow,et al. Second-generation PLINK: rising to the challenge of larger and richer datasets , 2014, GigaScience.
[16] S. Neupane,et al. High Frequency and Intensity of Drinking may Attenuate Increased Inflammatory Cytokine Levels of Major Depression in Alcohol‐use Disorders , 2014, CNS neuroscience & therapeutics.
[17] Yan Cui,et al. PolymiRTS Database 3.0: linking polymorphisms in microRNAs and their target sites with human diseases and biological pathways , 2013, Nucleic Acids Res..
[18] Tatiana Foroud,et al. Genetics and alcoholism , 2013, Nature Reviews Gastroenterology &Hepatology.
[19] Janet B W Williams,et al. Diagnostic and Statistical Manual of Mental Disorders , 2013 .
[20] Heng Li. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM , 2013, 1303.3997.
[21] B. Graveley,et al. Effects of cocaine and withdrawal on the mouse nucleus accumbens transcriptome , 2013, Genes, brain, and behavior.
[22] G. Siggins,et al. The central amygdala and alcohol: role of γ-aminobutyric acid, glutamate, and neuropeptides. , 2012, Cold Spring Harbor perspectives in medicine.
[23] Marcel Martin. Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .
[24] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[25] Y. Hannun,et al. Mammalian Neutral Sphingomyelinases: Regulation and Roles in Cell Signaling Responses , 2010, NeuroMolecular Medicine.
[26] C. Gong,et al. Deregulation of sphingolipid metabolism in Alzheimer's disease , 2010, Neurobiology of Aging.
[27] M. R. Diaz,et al. Chronic ethanol and withdrawal effects on kainate receptor-mediated excitatory neurotransmission in the rat basolateral amygdala. , 2009, Alcohol.
[28] M. Schuckit,et al. Genetic factors influencing alcohol dependence , 2008, British journal of pharmacology.
[29] P. Donnelly,et al. A new multipoint method for genome-wide association studies by imputation of genotypes , 2007, Nature Genetics.
[30] K. Pahan,et al. Fibrillar Amyloid-β Peptides Kill Human Primary Neurons via NADPH Oxidase-mediated Activation of Neutral Sphingomyelinase , 2004, Journal of Biological Chemistry.
[31] M. Katoh,et al. Identification and characterization of human TMEM25 and mouse Tmem25 genes in silico. , 2004, Oncology reports.
[32] J. Renau‐Piqueras,et al. Ceramide pathways modulate ethanol‐induced cell death in astrocytes , 2003, Journal of neurochemistry.
[33] A. Dagher,et al. Alcohol promotes dopamine release in the human nucleus accumbens , 2003, Synapse.
[34] A. Nilsson,et al. Activation of neutral sphingomyelinase participates in ethanol-induced apoptosis in Hep G2 cells. , 2000, Alcohol and alcoholism.
[35] J. Kril,et al. The cerebral cortex is damaged in chronic alcoholics , 1997, Neuroscience.
[36] J. Rabe-Jabłońska,et al. [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders]. , 1993, Psychiatria polska.
[37] J. Kornhuber,et al. Sphingolipids in psychiatric disorders and pain syndromes. , 2013, Handbook of experimental pharmacology.
[38] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[39] O. Delaneau,et al. Supplementary Information for ‘ Improved whole chromosome phasing for disease and population genetic studies ’ , 2012 .
[40] S. Tenenbaum,et al. Advances in RIP-chip analysis : RNA-binding protein immunoprecipitation-microarray profiling. , 2008, Methods in molecular biology.
[41] E. Stoeckli. Ig superfamily cell adhesion molecules in the brain. , 2004, Handbook of experimental pharmacology.
[42] K. Pahan,et al. Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease. , 2004, The Journal of biological chemistry.
[43] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .